ABCG2 and neoplasm: ABCG2 expression was significantly more frequent when assessed in resected tumor specimens (50%) compared to biopsies (26%) (P=0.04), while no difference was found comparing frequencies of ABCG2 expression in primary tumors (29% positive) or metastases (39% positive) (P=0.51).